K H Fife

Summary

Affiliation: Indiana University
Country: USA

Publications

  1. doi request reprint Herpes simplex virus type 2 infection in young adult women: risk factors for infection and frequency of viral shedding
    Kenneth H Fife
    Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    Sex Transm Dis 37:248-52. 2010
  2. ncbi request reprint Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial
    Kenneth H Fife
    Indiana University School of Medicine, Room 435 Emerson Hall, 545 Barnhill Dr, Indianapolis, IN 46202, USA
    Mayo Clin Proc 81:1321-7. 2006
  3. pmc Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy
    Kenneth H Fife
    Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202 5124, USA
    J Acquir Immune Defic Syndr 51:274-82. 2009
  4. doi request reprint Implementation of routine access to herpes simplex virus type 2 antibody testing in a public health sexually transmitted disease clinic
    Kenneth H Fife
    Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA
    Sex Transm Dis 36:724-8. 2009
  5. ncbi request reprint Predictors of herpes simplex virus type 2 antibody positivity among persons with no history of genital herpes
    Kenneth H Fife
    Department of Medicine, Indiana University School of Medicine, Indianapolis 46202, USA
    Sex Transm Dis 31:676-81. 2004
  6. doi request reprint An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients
    Kenneth H Fife
    Department of Medicine, Division of Infectious Diseases, Indiana University School of Medicine, Emerson Hall, Room 435, 545 Barnhill Drive, Indianapolis, IN 46202, USA
    Sex Transm Dis 35:668-73. 2008
  7. pmc Effect of resiquimod 0.01% gel on lesion healing and viral shedding when applied to genital herpes lesions
    Kenneth H Fife
    Division of Infectious Diseases, Departmernt of Medicine, Indiana University School of Medicine, Emerson Hall 435, 545 Barnhill Drive, Indianapolis, IN 46202, USA
    Antimicrob Agents Chemother 52:477-82. 2008
  8. ncbi request reprint A comparison of one year of episodic or suppressive treatment of recurrent genital herpes with valacyclovir
    Kenneth H Fife
    Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA
    Sex Transm Dis 34:297-301. 2007
  9. ncbi request reprint Poor sensitivity of polymerase chain reaction assays of genital skin swabs and urine to detect HPV 6 and 11 DNA in men
    Kenneth H Fife
    Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA
    Sex Transm Dis 30:246-8. 2003
  10. ncbi request reprint Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily, or three times a day
    K H Fife
    Department of Medicine, Indiana University School of Medicine, Indianapolis, USA
    Sex Transm Dis 28:226-31. 2001

Detail Information

Publications27

  1. doi request reprint Herpes simplex virus type 2 infection in young adult women: risk factors for infection and frequency of viral shedding
    Kenneth H Fife
    Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    Sex Transm Dis 37:248-52. 2010
    ..Population-based studies suggest that acquisition of herpes simplex virus 2 (HSV 2) is most common between ages 20 and 29, especially in minority women. We examined HSV 2 infection and viral shedding in a cohort of young women...
  2. ncbi request reprint Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial
    Kenneth H Fife
    Indiana University School of Medicine, Room 435 Emerson Hall, 545 Barnhill Dr, Indianapolis, IN 46202, USA
    Mayo Clin Proc 81:1321-7. 2006
    ....
  3. pmc Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy
    Kenneth H Fife
    Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202 5124, USA
    J Acquir Immune Defic Syndr 51:274-82. 2009
    ....
  4. doi request reprint Implementation of routine access to herpes simplex virus type 2 antibody testing in a public health sexually transmitted disease clinic
    Kenneth H Fife
    Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA
    Sex Transm Dis 36:724-8. 2009
    ..Client characteristics associated with HSV-2 rapid antibody test uptake and test positivity were analyzed in clients attending an urban sexually transmitted disease clinic...
  5. ncbi request reprint Predictors of herpes simplex virus type 2 antibody positivity among persons with no history of genital herpes
    Kenneth H Fife
    Department of Medicine, Indiana University School of Medicine, Indianapolis 46202, USA
    Sex Transm Dis 31:676-81. 2004
    ..The demographic, historical, and behavioral factors that predict a positive herpes simplex virus type 2 (HSV-2) antibody test in persons without a history of genital herpes have not been well-defined...
  6. doi request reprint An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients
    Kenneth H Fife
    Department of Medicine, Division of Infectious Diseases, Indiana University School of Medicine, Emerson Hall, Room 435, 545 Barnhill Drive, Indianapolis, IN 46202, USA
    Sex Transm Dis 35:668-73. 2008
    ....
  7. pmc Effect of resiquimod 0.01% gel on lesion healing and viral shedding when applied to genital herpes lesions
    Kenneth H Fife
    Division of Infectious Diseases, Departmernt of Medicine, Indiana University School of Medicine, Emerson Hall 435, 545 Barnhill Drive, Indianapolis, IN 46202, USA
    Antimicrob Agents Chemother 52:477-82. 2008
    ..471; 95% confidence interval, 0.786 to 2.754; P = 0.227). Application of resiquimod 0.01% two times per week for 3 weeks did not delay the healing of genital herpes lesions or reduce acute viral shedding...
  8. ncbi request reprint A comparison of one year of episodic or suppressive treatment of recurrent genital herpes with valacyclovir
    Kenneth H Fife
    Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA
    Sex Transm Dis 34:297-301. 2007
    ..We conducted this study to compare episodic and suppressive therapy for genital herpes about disease characteristics, disease burden, and psychologic impact...
  9. ncbi request reprint Poor sensitivity of polymerase chain reaction assays of genital skin swabs and urine to detect HPV 6 and 11 DNA in men
    Kenneth H Fife
    Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA
    Sex Transm Dis 30:246-8. 2003
    ..A possible reason for the failure to detect human papillomavirus (HPV) DNA in asymptomatic men who are likely to be infected is the sensitivity of the detection methods...
  10. ncbi request reprint Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily, or three times a day
    K H Fife
    Department of Medicine, Indiana University School of Medicine, Indianapolis, USA
    Sex Transm Dis 28:226-31. 2001
    ..When 5% imiquimod cream is applied three times a week up to 16 weeks, approximately two thirds of women treated with imiquimod achieve complete clearance of genital warts, whereas only about one third of men clear completely...
  11. ncbi request reprint Incidence and prevalence of herpes simplex virus infections in adolescent women
    Kenneth H Fife
    Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
    Sex Transm Dis 33:441-4. 2006
    ..We conducted this study to examine the incidence, prevalence, and risk factors for herpes simplex virus (HSV) 1 and HSV 2 infection in a cohort of young women who were closely followed for acquisition of sexually transmitted infections...
  12. ncbi request reprint Neutralization of human papillomavirus type 11 (HPV-11) by serum from women vaccinated with yeast-derived HPV-11 L1 virus-like particles: correlation with competitive radioimmunoassay titer
    D R Brown
    Indiana University School of Medicine and Roudebush Veterans Administration Hospital, 545 Barnhill Dr, Indianapolis, IN 46202, USA
    J Infect Dis 184:1183-6. 2001
    ..Immunization with HPV VLPs elicits a vigorous serum immune response in a high percentage of women. The HPV-11 cRIA titer appears to be a surrogate marker for neutralization...
  13. ncbi request reprint Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia
    K H Fife
    Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA
    J Med Virol 64:550-9. 2001
    ..04 (range 0-7) HPV types among those with normal cytology (P < 0.0001). These data support a possible role for multiple HPV types in the development or progression of cervical dysplasia...
  14. pmc Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients
    D R Brown
    Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202 5124, USA
    J Clin Microbiol 37:3316-22. 1999
    ..Further studies are needed to determine the influence these additional HPV types have on the epidemiology of genital tract HPV infections and the natural history of condylomata acuminata, especially in immunosuppressed patients...
  15. ncbi request reprint Dose-ranging studies of the safety and immunogenicity of human papillomavirus Type 11 and Type 16 virus-like particle candidate vaccines in young healthy women
    Kenneth H Fife
    Department of Medicine, Indiana University School of Medicine, Indianapolis, USA
    Vaccine 22:2943-52. 2004
    ..Antibody to HPV11 and 16 was still present at Month 36 in 96.8 and 93.5% of vaccinees, respectively. Both vaccines were well tolerated and were associated with only mild to moderate injection-site reactions...
  16. ncbi request reprint Factors predicting the acceptance of herpes simplex virus type 2 antibody testing among adolescents and young adults
    Gregory D Zimet
    Department of Pediatrics, Indiana University School of Medicine, Indianapolis, USA
    Sex Transm Dis 31:665-9. 2004
    ..The rates and determinants of acceptance of herpes simplex virus type 2 (HSV-2) testing have not been adequately studied...
  17. ncbi request reprint Return for results after herpes simplex virus type 2 screening
    J Dennis Fortenberry
    Indiana University School of Medicine, Indianapolis, USA
    Sex Transm Dis 31:655-8. 2004
    ..The objective of this study was to evaluate factors associated with return for results of type-specific herpes simplex virus (HSV) screening...
  18. ncbi request reprint Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccine
    Darron R Brown
    Department of Medicine, Indiana University School of Medicine, Emerson Hall Room 435, 545 Barnhill Drive, Indianapolis 46022, USA
    Vaccine 22:2936-42. 2004
    ..These results support the institution of larger efficacy trials for HPV L1 VLP vaccines...
  19. ncbi request reprint Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya
    Kara Wools-Kaloustian
    Division of Infectious Diseases, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    AIDS 20:41-8. 2006
    ..To determine the clinical and immunological outcomes of a cohort of HIV-infected patients receiving antiretroviral therapy...
  20. ncbi request reprint Growth of molluscum contagiosum virus in a human foreskin xenograft model
    K H Fife
    Department of Medicine, Indiana University School of Medicine, Indianapolis, USA
    Virology 226:95-101. 1996
    ..A limited number of attempts to pass virus from one infected implant to another were not successful. This system is the most rapid and reproducible for growing MCV that has been reported to date...
  21. pmc Functional characterization of the C---C chemokine-like molecules encoded by molluscum contagiosum virus types 1 and 2
    M D Krathwohl
    Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    Proc Natl Acad Sci U S A 94:9875-80. 1997
    ..The significance of hematopoietic progenitor cell inhibition in viral pathogenesis is uncertain...
  22. doi request reprint Bariatric surgery outcomes in HIV-infected subjects: a case series
    Henry Selke
    Department of Medicine, Division of Infectious Diseases, Indiana University School of Medicine, Indianapolis, Indiana, USA
    AIDS Patient Care STDS 24:545-50. 2010
    ..Larger studies are needed to verify these results, especially in regards to surgical complications...
  23. ncbi request reprint Are the antiherpes nucleosides really all the same?
    Kenneth H Fife
    Sex Transm Dis 33:534-5. 2006
  24. ncbi request reprint The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes
    Rhoda S Sperling
    Mount Sinai Medical Center, New York City, New York, USA
    Sex Transm Dis 35:286-90. 2008
    ..These individuals can transmit disease during periods of asymptomatic viral shedding. The frequency of asymptomatic shedding and the efficacy of antiviral therapy in reducing shedding has not been assessed in this population...
  25. ncbi request reprint Herpes virus type 2 infection and genital symptoms in primary care patients
    Douglas T Fleming
    Mathematica Policy Research, Inc, Princeton, New Jersey, USA
    Sex Transm Dis 33:416-21. 2006
    ..We aimed to identify whether genital symptoms were associated with unrecognized herpes simplex virus type 2 (HSV-2) infection in a primary care population...
  26. ncbi request reprint A randomized controlled trial of a replication defective (gH deletion) herpes simplex virus vaccine for the treatment of recurrent genital herpes among immunocompetent subjects
    Guy de Bruyn
    Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Vaccine 24:914-20. 2006
    ..A replication incompetent herpes virus lacking the glycoprotein H gene has been developed as a potential therapeutic vaccine for genital herpes...
  27. pmc The Centers for Disease Control and Prevention revised recommendations for HIV testing: reactions of women attending community health clinics
    Joe W Burrage
    Indiana University School of Nursing, USA
    J Assoc Nurses AIDS Care 19:66-74. 2008
    ..In general, respondents believed that verbal informed consent for testing as well as provision of HIV-related information before and after testing were crucial...